117 related articles for article (PubMed ID: 22850805)
1. Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.
Li F; Shen Z; Lu Y; Yun J; Fan Y
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1731-4. PubMed ID: 22850805
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
3. Relationship between prostate-specific antigen and hematocrit: does hemodilution lead to lower PSA concentrations in men with a higher body mass index?
Ohwaki K; Endo F; Muraishi O; Hiramatsu S; Yano E
Urology; 2010 Mar; 75(3):648-52. PubMed ID: 19854477
[TBL] [Abstract][Full Text] [Related]
4. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
5. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
6. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
[TBL] [Abstract][Full Text] [Related]
7. Obesity and screening PSA levels among men undergoing an annual physical exam.
Rundle A; Neugut AI
Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
[TBL] [Abstract][Full Text] [Related]
8. Variance inflation in sequential calculations of body surface area, plasma volume, and prostate-specific antigen mass.
Sivanandam A; Siva S; Bhandari M; Menon M
BJU Int; 2008 Dec; 102(11):1573-80. PubMed ID: 18691174
[TBL] [Abstract][Full Text] [Related]
9. Serum prostate-specific antigen is better correlated to body surface area than body mass index in a population of healthy Korean men.
Song M; Doo SW; Yang WJ; Song YS; Kim Y
Int J Urol; 2010 Jun; 17(6):580-3. PubMed ID: 20370844
[TBL] [Abstract][Full Text] [Related]
10. Plasma volume changes affect prostate specific antigen in healthy men.
Ohwaki K; Endo F; Muraishi O; Yano E
J Urol; 2010 Apr; 183(4):1349-53. PubMed ID: 20171686
[TBL] [Abstract][Full Text] [Related]
11. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
[TBL] [Abstract][Full Text] [Related]
12. The illusion of prostate-specific antigen decline in patients with metabolic syndrome and insulin resistance.
Choi HC; Park JH; Cho BL; Son KY; Yoo YJ; Kwon HT
BJU Int; 2011 Dec; 108(11):1756-61. PubMed ID: 21507191
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].
Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525
[TBL] [Abstract][Full Text] [Related]
15. How much does body mass index affect serum carcinoembryonic antigen concentration?
Li F; Shen Z; Lu Y; Wang L; Song W
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):555-60. PubMed ID: 24425143
[TBL] [Abstract][Full Text] [Related]
16. Which obesity index best correlates with prostate volume, prostate-specific antigen, and lower urinary tract symptoms?
Yang HJ; Doo SW; Yang WJ; Song YS
Urology; 2012 Jul; 80(1):187-90. PubMed ID: 22626573
[TBL] [Abstract][Full Text] [Related]
17. Modeling the effects of obesity and weight gain on PSA velocity.
Rundle AG; Neugut AI
Prostate; 2009 Oct; 69(14):1573-8. PubMed ID: 19562734
[TBL] [Abstract][Full Text] [Related]
18. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
19. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.
Werny DM; Thompson T; Saraiya M; Freedman D; Kottiri BJ; German RR; Wener M
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):70-6. PubMed ID: 17179487
[TBL] [Abstract][Full Text] [Related]
20. Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
Klaassen Z; Howard LE; Moreira DM; Andriole GL; Terris MK; Freedland SJ
Prostate; 2017 Apr; 77(5):466-470. PubMed ID: 27990661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]